Half-year liquidity contract statement for Sartorius Stedim Biotech
Sartorius Stedim Biotech SA
Half-year liquidity contract statement for Sartorius Stedim Biotech
05-Jan-2023 / 11:18 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
Aubagne, January 1, 2023
Half-year liquidity contract statement for Sartorius Stedim Biotech
Under the liquidity contract entered into between Sartorius Stedim Biotech and Kepler Cheuvreux, the following resources appeared on the liquidity account on December 31st 2022:
11,901 shares € 6,837,423.41 Number of executions on buy side on semester: 4,259 Number of executions on sell side on semester: 4,361 Traded volume on buy side on semester: 166,507 shares for € 56,282,984.47 Traded volume on sell side on semester: 174,847 shares for € 59,810,740.92
As a reminder, the following resources appeared on the last half year statement on 30 June 2022 on the liquidity account:
20,241 shares € 3,286,293.04 Number of executions on buy side on semester: 4,639 Number of executions on sell side on semester: 4,205 Traded volume on buy side on semester: 186,508 shares for € 64,215,074.25 Traded volume on sell side on semester: 169,628 shares for € 57,532,559.42
The following resources appeared on the liquidity account when the activity started:
0 shares € 10,000,000.00
The implementation of this report is carried out in accordance with AMF Decision N°2021-01 of June 22nd 2021 renewing the implementation of liquidity contracts for shares as an accepted market practice.
A profile of Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading international partner of the biopharmaceutical industry. As a total solutions provider, the company helps its customers to manufacture biotech medications safely, rapidly and economically. Headquartered in Aubagne, France, the shares of Sartorius Stedim Biotech S.A. are quoted on the Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and an international network of sales companies, Sartorius Stedim Biotech has a global reach. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions of complementary technologies. In 2021, the company employed more than 10,400 people, and earned sales revenue of around 2.89 billion euros.
Contact
Petra Müller
Head of Investor Relations
+49 (0)551.308.6035
Petra.mueller2@sartorius.com
Sartorius Stedim Biotech S.A.
Z.I. Les Paluds
Avenue de Jouques, CS 91051
13781 Aubagne Cedex, France
Phone: +33.(0)4.42.84.56.00
Fax: +33.(0)4.42.84.56.19
www.sartorius.com
Buy side
Sell side
Number of executions
Number of shares
Traded volume in EUR
Number of executions
Number of shares
Traded volume in EUR
TOTAL
4,259
166,507
56,282,984.47
4,361
174,847
59,810,740.92
01/07/2022
28
711
210,185.82
26
1,500
448,695.00
04/07/2022
7
305
93,946.10
33
1,200
370,344.00
05/07/2022
6
363
115,513.86
42
2,000
640,140.00
06/07/2022
34
1,400
445,396.00
15
500
161,800.00
07/07/2022
35
1,600
524,704.00
38
1,600
529,648.00
08/07/2022
33
1,200
392,316.00
35
1,600
528,624.00
11/07/2022
13
600
201,300.00
18
1,200
404,316.00
12/07/2022
29
1,300
437,294.00
26
1,200
406,680.00
13/07/2022
39
1,500
502,605.00
19
1,000
337,700.00
14/07/2022
37
1,700
568,497.00
25
1,339
450,386.04
15/07/2022
12
700
232,603.00
33
1,300
435,994.00
18/07/2022
38
1,300
431,665.00
12
200
68,800.00
19/07/2022
25
900
290,646.00
33
1,400
460,614.00
20/07/2022
-
-
-
24
900
304,209.00
21/07/2022
14
405
135,670.95
90
2,900
1,026,600.00
22/07/2022
-
-
-
13
800
304,072.00
25/07/2022
53
1,756
640,975.12
2
100
37,100.00
26/07/2022
18
1,000
363,000.00
22
1,100
400,697.00
27/07/2022
10
500
181,900.00
37
1,500
551,220.00
28/07/2022
20
1,016
372,526.56
51
2,400
897,792.00
29/07/2022
-
-
-
32
1,400
537,698.00
01/08/2022
12
601
233,188.00
28
1,200
469,596.00
02/08/2022
37
1,400
539,700.00
32
1,400
542,906.00
03/08/2022
44
1,600
611,104.00
38
1,600
615,504.00
04/08/2022
14
700
269,199.00
19
817
315,582.59
05/08/2022
60
2,700
1,021,275.00
12
500
194,100.00
08/08/2022
22
1,100
409,596.00
29
1,100
412,401.00
09/08/2022
32
1,407
521,673.39
29
1,000
372,350.00
10/08/2022
57
1,377
499,066.11
53
2,900
1,076,393.00
11/08/2022
4
200
74,700.00
98
3,100
1,180,759.00
12/08/2022
32
1,500
572,925.00
28
1,400
536,606.00
15/08/2022
12
700
269,703.00
28
1,500
580,800.00
16/08/2022
29
1,500
574,695.00
45
2,000
772,800.00
17/08/2022
9
100
38,700.00
24
1,300
511,797.00
18/08/2022
9
700
276,598.00
24
1,000
397,700.00
19/08/2022
26
1,200
473,196.00
14
800
317,400.00
22/08/2022
69
1,800
694,188.00
5
391
151,309.18
23/08/2022
74
2,000
749,580.00
25
891
335,737.71
24/08/2022
31
700
259,490.00
40
2,079
783,387.99
25/08/2022
10
500
194,200.00
31
1,600
624,784.00
26/08/2022
51
2,400
922,896.00
16
1,000
388,400.00
29/08/2022
48
1,700
630,921.00
17
1,100
412,335.00
30/08/2022
37
1,000
368,580.00
26
1,200
445,896.00
31/08/2022
34
1,700
621,894.00
33
1,600
591,504.00
01/09/2022
42
1,731
626,223.87
28
1,500
546,465.00
02/09/2022
5
300
109,500.00
30
800
294,304.00
05/09/2022
35
900
326,259.00
19
1,100
401,401.00
06/09/2022
26
1,500
553,905.00
25
1,700
631,295.00
07/09/2022
61
1,500
551,595.00
31
1,600
591,504.00
08/09/2022
27
1,300
479,401.00
39
1,900
707,275.00
09/09/2022
12
525
200,224.50
37
1,700
650,947.00
Buy side
Sell side
Number of executions
Number of shares
Traded volume in EUR
Number of executions
Number of shares
Traded volume in EUR
TOTAL
4,259
166,507
56,282,984.47
4,361
174,847
59,810,740.92
12/09/2022
36
1,378
527,002.32
55
1,700
653,803.00
13/09/2022
61
2,497
957,050.16
25
1,200
469,596.00
14/09/2022
41
1,428
533,172.36
35
1,500
563,295.00
15/09/2022
60
1,900
706,097.00
20
1,000
376,300.00
16/09/2022
135
3,664
1,285,404.48
-
-
-
19/09/2022
15
400
133,000.00
-
-
-
20/09/2022
41
1,900
623,504.00
12
400
134,980.00
21/09/2022
31
1,000
321,500.00
39
1,515
490,420.65
22/09/2022
86
2,000
642,340.00
16
800
261,104.00
23/09/2022
31
1,500
462,705.00
48
1,816
563,559.28
26/09/2022
28
1,010
322,806.10
52
2,184
701,544.48
27/09/2022
52
2,090
655,131.40
70
1,300
413,595.00
28/09/2022
31
1,400
434,602.00
37
1,500
469,605.00
29/09/2022
40
1,300
400,361.00
33
1,200
371,124.00
30/09/2022
6
300
91,800.00
26
1,200
374,940.00
03/10/2022
40
1,100
343,893.00
60
2,100
666,498.00
04/10/2022
-
-
-
51
1,900
637,602.00
05/10/2022
47
1,800
627,102.00
50
2,000
702,000.00
06/10/2022
19
900
314,001.00
58
1,900
665,323.00
07/10/2022
53
2,200
756,910.00
12
700
242,900.00
10/10/2022
71
1,908
633,608.64
28
1,000
334,600.00
11/10/2022
58
2,000
651,000.00
56
2,200
720,896.00
12/10/2022
46
1,900
618,754.00
22
1,100
360,701.00
13/10/2022
50
1,900
603,991.00
56
2,300
738,990.00
14/10/2022
33
1,600
531,456.00
67
2,900
978,808.00
17/10/2022
23
1,100
367,796.00
37
2,000
678,300.00
18/10/2022
13
600
206,598.00
64
1,900
661,998.00
19/10/2022
134
5,889
1,833,540.15
-
-
-
20/10/2022
18
839
244,006.37
51
2,468
738,993.24
21/10/2022
44
1,700
500,497.00
25
1,400
417,802.00
24/10/2022
23
900
274,203.00
42
1,600
492,048.00
25/10/2022
14
600
182,898.00
37
1,905
589,807.05
26/10/2022
12
700
223,797.00
46
1,900
612,104.00
27/10/2022
42
1,400
453,306.00
27
900
292,797.00
28/10/2022
55
1,400
447,944.00
31
1,200
385,728.00
31/10/2022
11
600
193,098.00
13
400
129,920.00
01/11/2022
25
1,100
348,370.00
21
700
228,340.00
02/11/2022
4
200
62,700.00
17
800
255,600.00
03/11/2022
45
1,334
411,512.32
14
500
155,200.00
04/11/2022
13
619
189,178.78
14
600
186,300.00
07/11/2022
8
581
178,425.10
29
1,200
370,704.00
08/11/2022
9
500
153,890.00
71
2,100
664,398.00
09/11/2022
13
1,100
355,597.00
68
1,600
521,296.00
10/11/2022
39
1,300
417,365.00
71
2,400
785,616.00
11/11/2022
9
300
104,100.00
27
600
212,760.00
14/11/2022
24
1,166
413,335.34
42
1,600
569,696.00
15/11/2022
68
2,934
1,031,477.04
68
2,200
779,526.00
16/11/2022
59
2,100
721,098.00
9
500
175,800.00
17/11/2022
40
1,800
601,794.00
19
900
303,903.00
18/11/2022
38
1,400
459,704.00
54
1,822
601,096.02
21/11/2022
48
1,921
633,603.43
53
1,900
629,508.00
Buy side
Sell side
Number of executions
Number of shares
Traded volume in EUR
Number of executions
Number of shares
Traded volume in EUR
TOTAL
4,259
166,507
56,282,984.47
4,361
174,847
59,810,740.92
22/11/2022
46
1,679
544,583.65
28
1,400
455,798.00
23/11/2022
36
1,338
434,582.40
32
1,400
457,380.00
24/11/2022
9
662
218,413.66
46
1,300
432,406.00
25/11/2022
33
1,600
537,808.00
55
1,900
641,098.00
28/11/2022
63
2,700
907,308.00
62
1,744
589,158.08
29/11/2022
52
2,200
713,878.00
6
500
163,700.00
30/11/2022
19
800
256,904.00
39
1,620
522,822.60
01/12/2022
1
100
33,500.00
70
2,356
794,184.04
02/12/2022
20
900
304,497.00
17
793
270,912.59
05/12/2022
10
600
202,182.00
18
507
171,589.08
06/12/2022
51
2,000
661,340.00
18
700
233,597.00
07/12/2022
73
1,600
516,208.00
22
900
291,204.00
08/12/2022
30
1,700
531,794.00
33
1,500
474,105.00
09/12/2022
34
1,500
475,995.00
40
1,700
544,595.00
12/12/2022
25
1,100
346,995.00
48
1,500
475,395.00
13/12/2022
19
800
253,160.00
56
2,200
709,896.00
14/12/2022
29
1,100
358,699.00
52
1,200
393,024.00
15/12/2022
49
2,500
801,225.00
20
800
258,120.00
16/12/2022
50
2,130
654,059.10
9
500
153,940.00
19/12/2022
45
2,000
601,340.00
33
1,216
368,606.08
20/12/2022
33
1,300
383,396.00
20
1,100
325,952.00
21/12/2022
24
1,200
356,400.00
51
1,587
473,227.53
22/12/2022
29
1,500
452,745.00
28
1,297
393,989.69
23/12/2022
45
1,900
568,537.00
36
1,700
511,003.00
27/12/2022
24
1,100
331,903.00
35
1,100
333,718.00
28/12/2022
11
743
223,442.39
22
1,000
301,800.00
29/12/2022
19
600
181,842.00
52
1,700
520,047.00
30/12/2022
26
1,400
428,302.00
6
200
61,680.00
File: Half-year liquidity contract statement for Sartorius Stedim Biotech
Language: English Company: Sartorius Stedim Biotech SA Avenue de Jouques 13781 Aubagne France Phone: +33 44 284 5600 E-mail: info@sartorius-stedim.com Internet: www.sartorius-stedim.com ISIN: FR0013154002 Euronext Ticker: DIM AMF Category: Share buyback / Disposal of own shares / Information relating to the liquidity contract EQS News ID: 1527971 End of Announcement EQS News Service
1527971 05-Jan-2023 CET/CEST